|Bid||4.86 x 7600|
|Ask||4.87 x 2000|
|Day's Range||4.21 - 4.96|
|52 Week Range||1.74 - 4.96|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Geron (GERN) misses earnings and sales estimates in Q4. However, revenues almost double year over year. Imetelstat remains in focus.
Geron Corp.’s grip over the cloning industry began to unravel last August when its exclusivity rights to technology in the sector expired. Now, some foresee a land grab with more firms quietly buying interests ...
On a per-share basis, the Menlo Park, California-based company said it had a loss of 5 cents. The drugmaker posted revenue of $191,000 in the period. For the year, the company reported that its loss narrowed ...
Geron Corporation’s (NASDAQ:GERN): Geron Corporation operates as a biopharmaceutical company. With the latest financial year loss of -US$29.54M and a trailing-twelve month of -US$28.97M, the US$466.55M market-cap alleviates its lossRead More...
With no approved product in Geron's (GERN) portfolio, investor focus is likely to remain on its sole pipeline candidate, imetelstat, in the Q4 release.
Analysts are bullish on these following companies: GW Pharmaceuticals, Geron, SmartFinancial. These companies are relatively strong financially, and have a great outlook in terms of profits and cash flow. IfRead More...
Stocks are finding their footing on Wednesday, with the Dow Jones Industrial Average holding with a gain of more than 100 points as of this writing. Meanwhile, the CBOE Volatility Index is falling back to earth and investors are leaving their panic attack. Not with major, secular headwinds building including inflation, higher interest rates popping the bond bubble and a new Federal Reserve chairman that seems set on holding to the rate hike path.
Assessing Geron Corporation’s (NASDAQ:GERN) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check to buildRead More...
Discussions with potential offerors China Great United Petroleum (Holding) Limited (CGUP) and Geron Energy Investment (Geron) have been terminated, San Leon confirms.
Two specialized small-cap drug developers, and a financial holding company share similar traits to software giant Microsoft from three decades ago.
Why invest in a stock whose growth outlook that lags behind the market? Investors looking for companies with extraordinary future prospects in terms of profitability and returns should look atRead More...